Cenforce 150 mg is a anti erectile dysfunction medicine contains Sildenafil used to achieve & maintains a firm erection. It help men supply blood flow to the penis by inhibiting The active ingredient of Cenforce 150 mg is sildenafil citrate, specifically, at a 150 mg concentration, which makes it a high-strength dose. It belongs to the class of PDE-5 inhibitors, which is an enzyme involved in the circulatory process.
Cenforce 150 mg contains the key ingredient, sildenafil citrate, which was initially developed by Pfizer in 1998. It was formulated for the treatment of angina and persistent hypertension. While its efficacy against angina was not shown, a notable side effect was noted. Men who participated in this trial reported improved erectile function. As a result, research on sildenafil citrate was shifted to focus on erectile dysfunction as the main indication.
Finally, the United States Food and Drug Administration approved sildenafil citrate (brand name Viagra) for the treatment of erectile dysfunction in 1998. Sildenafil citrate was then licensed in 2005 for the treatment of pulmonary arterial hypertension (PAH) under the trade name Revatio.
ED refers to the inability of an adult human male to achieve or sustain an erection for a minimum required amount of time. Cenforce 100 mg facilitates better penile tissue function and improved blood flow in the penis.
PAH is characterized by excessive constriction of the pulmonary artery, which causes excessive blood pressure in the pulmonary artery. For this indication, Cenforce 100 mg improves the blood flow to the lungs and heart by facilitating vasodilation. As a result, the blood pressure in the pulmonary artery is reduced.
Dosage
(Cenforce 150 mg contains 150 mg sildenafil; this strength is higher than the usual starting dose and should only be used if specifically prescribed.)
Erectile Dysfunction (On-label)
Overdosing instructions: Seek immediate medical attentionif symptoms such as severe headache, dizziness, vision disturbances, chest pain, fainting, or prolonged erection (priapism >4 hours).
Pulmonary Arterial Hypertension (PAH)
Overdosing instructions: Immediate medical care is required. Side effects include severe hypotension, fainting, visual changes, or cardiac complications.
Raynaud’s Phenomenon (Off-label)
Cenforce 150 mg contains 150 milligrams of sildenafil citrate. This drug belongs to the class of PDE-5 inhibitors. It targets the NO-cGMP pathway, which is involved in local blood circulation and other physiological changes.
Generally, the NO-cGMP pathway is activated after an external trigger (sexual stimulation, nervous activation, endothelial shear stress). On an external trigger, the nerve cells/ endothelial tissues release nitric oxide (NO), which diffuses rapidly in the surrounding tissues. NO activates an enzyme called guanylate cyclase, which converts the inactive guanosine triphosphate (GTP) into highly active cyclic guanosine monophosphate (cGMP).
The cGMP molecules facilitate smooth muscle relaxation and blood vessel dilation (vasodilation). This also improves blood flow to the organ or tissue. These processes are required for normal physiological responses to external stimuli. They are essential for the production of an erection, ensuring proper blood circulation, and performing other metabolic functions.
When a significant quantity of cGMP molecules has been accumulated, an enzyme called phosphodiesterase type-5 (PDE-5) is activated. This enzyme is constitutively present in tissues where the NO-cGMP pathway is active. It is released in response to a high concentration of cGMPs through a feedback mechanism.
The PDE-5 destroys the cGMP molecules, reducing their physiological effects. This constricts the blood vessels and tones the smooth muscles. These reactions are necessary to return the body to its normal resting state. Without the PDE-5 enzyme, vasodilation and relaxed tissues would last indefinitely. These can result in unusual conditions such as extended erections or severe dilation of the pulmonary vessels.
In certain situations, effects due to the PDE-5 enzyme may be premature or excessive. This stops the cGMP molecules from performing their regular physiological reactions to the full extent. This abnormality can result in conditions like erectile dysfunction and pulmonary arterial hypertension.
Cenforce 150 mg selectively targets the PDE-5 enzymes, allowing appropriate concentrations of cGMP molecules to accumulate in the tissue. As a result, the blood vessels receive adequate blood flow, and the smooth muscle tissues relax to the appropriate extent. Cenforce 150 mg is thus a useful treatment for disorders caused by excessive PDE-5 enzyme activity.
Very Common
Headache
Common
Rash
Uncommon
Ringing in ears (tinnitus)
Rare
Urticaria (hives)
Very Rare / Serious
Cenforce 150 mg must be consumed only if prescribed by a licensed healthcare provider.
Individuals must stick to the dosing schedule and strength as prescribed by the healthcare provider.
Individuals must inform doctors about any medical history, ongoing medication, allergies, etc., before consuming this medication.
Certain items, such as alcohol and grapefruit, must not be consumed alongwith Cenforce 150 mg.
Interactions
Blood pressure-lowering medications
These substances usually comprise nitrates, nitric oxide donors, alpha blockers, and antihypertensive agents. Cenforce 150 mg also lowers blood pressure by vasodilation. If these medications are used in combination with Cenforce 150 mg, there is a risk of a serious, perhaps fatal reduction in blood pressure, which can cause shock, fainting, a heart attack, or stroke.
Strong medicines that alter the CYP3A4 enzyme
Cenforce 150 mg contains sildenafil citrate, which is metabolized by the CYP3A4 enzyme. Any drugs that inhibit the activity of this enzyme cause sildenafil citrate to remain in the body for an extended period of time. This raises the chances of side effects such as hypotension, priapism, and vision-related problems.
Similarly, CYP3A4 inducers accelerate the metabolism of sildenafil citrate, reducing its half-life. Due to low plasma concentrations, the effects of Cenforce 150 mg are reduced or may not be adequate.
Other PDE-5 inhibitors.
PDE-5 inhibiting enzymes produce a vasodilatory effect similar to Cenforce 150 mg. Combining Cenforce 150 mg with other PDE-5 inhibitors results in severe vasodilation. This causes abnormally low blood pressure and can lead to potentially life-threatening situations.
Cenforce 150 mg has a half-life of approximately 3-5 hours, with effects lasting up to 6 hours.
Yes. Cenforce 150 mg may be taken with or without food. However, eating heavy or fat-rich meals can slow the onset of its effects.
Cenforce 150 mg enhances the body's inherent biochemical and physiological functions. It does not, however, spontaneously cause an erection or improve sexual drive.
Yes. Alcohol has various potency-reducing effects, including increased dizziness and fainting risk, worse erectile quality, and an increased likelihood of adverse effects. As a result, the potency of Cenforce 150 mg is diminished due to alcohol consumption.
Cenforce 150 mg requires at least 30-60 minutes to take action.
Be the first to share your experience with this product!